Efficacy of meropenem and amikacin combination therapy against carbapenemase-producing Klebsiella pneumoniae mouse model of pneumonia.

Ota, Kenji; Kaku, Norihito; Yanagihara, Katsunori

Ota, Kenji; Kaku, Norihito; Yanagihara, Katsunori.

Afiliação

Ota K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Kaku N; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan. Electronic address: kaku-ngs@umin.ac.jp.
Yanagihara K; Department of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.

J Infect Chemother ; 26(12): 1237-1243, 2020 Dec.

Article em En | MEDLINE | ID: mdl-32868198

Assuntos

Enterobacteriáceas Resistentes a Carbapenêmicos; Infecções por Klebsiella; Pneumonia; Amicacina/uso terapêutico; Animais; Antibacterianos/uso terapêutico; Proteínas de Bactérias; Infecções por Klebsiella/tratamento farmacológico; Klebsiella pneumoniae; Meropeném/uso terapêutico; Camundongos; Camundongos Endogâmicos BALB C; Testes de Sensibilidade Microbiana; Pneumonia/tratamento farmacológico; beta-Lactamases

Palavras-chave

Antibiotic combination therapy; CPE; CRE; In vivo; Pneumonia mouse model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Infecções por Klebsiella / Enterobacteriáceas Resistentes a Carbapenêmicos Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google